Pular para o conteúdo
Merck
  • Rhodotorula spp. fungemia in an immunocompromised boy after neurosurgery successfully treated with miconazole and 5-flucytosine: case report and review of the literature.

Rhodotorula spp. fungemia in an immunocompromised boy after neurosurgery successfully treated with miconazole and 5-flucytosine: case report and review of the literature.

Chemotherapy (1994-07-01)
I Marinová, V Szabadosová, O Brandeburová, V Krcméry
RESUMO

A case of Rhodotorula fungemia in a 13-year-old boy after neurosurgery successfully treated with miconazole and 5-flucytosine is reported. Intravascular catheter insertion, broad-spectrum anti-miocrobials, surgery, and immunosuppression are the main risk factors for fungemia.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
5-Fluorocytosine, nucleoside analog
Miconazole, European Pharmacopoeia (EP) Reference Standard
Flucytosine, European Pharmacopoeia (EP) Reference Standard